Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People diagnosed with borderline resectable or locally advanced pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer), as defined by standard oncology guidelines (confirm with trial site)
- People whose cancer diagnosis has been confirmed through a tissue sample (biopsy or similar)
- People who are medically suitable to undergo surgery and tolerate anaesthesia
- People who are able to understand what the study involves
- People who are willing to take part and sign a written consent form
Who may not be able to join:
- People under 18 years of age
- People whose cancer has spread to distant parts of the body
- People whose tissue sample shows a different type of cancer, such as bile duct cancer, duodenal cancer, or a neuroendocrine tumour
- People with a known allergic reaction to MRI contrast dye
- People with a pacemaker or certain implants that are not compatible with MRI scanning
- People who experience claustrophobia (fear of enclosed spaces)
- People who are pregnant or breastfeeding
- People who are not able to understand what the study procedures involve
- People with a low general health and activity level, rated above 2 on the ECOG performance scale (a medical measure of how much a person's illness limits daily activities — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prediction of surgical resectability; R1 resection rate; Histopathological response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.